RxDoctor Payments Data

Akshal Patel, MD

Neurological Surgery · Seattle, WANPI 1447451562

Payments from drug & device makers

What this record shows

15 manufacturers reported payments, led by Balt USA, LLC at 59.8% of the total. Reporting peaked in 2024 at $3,422 and has fallen 85.0% since, to $515 in 2025.

$8,971in general payments, 2019–2025

Across 108 payments — averaging $83.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Balt USA, LLC$5K
  • Globus Medical$823
  • Imperative Care, Inc$663
  • Silk Road Medical, Inc.$653
  • Medtronic$428
  • Microvention, Inc.$365
  • plus $672 from 9 others
$50,290in research payments, 2019–2025

Across 15 payments — averaging $3352.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Penumbra, Inc.$50K

What the payments were for

  • Travel & lodging$3,62240%
  • Food & beverage$5,34960%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,971 in reported general payments places this provider in the 70th percentile of 175 neurological surgery providers in Washington.

See all neurological surgery providers in Washington

Medicare billing

Part B allowed, 2024
$296,184
Medicare patients
223
Services billed
692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate57$551
Mupirocin16$106

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →